Download PDF
J Reconstr Microsurg 2018; 34(01): 047-058
DOI: 10.1055/s-0037-1606339
Original Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Surgical Duration Impacts Venous Thromboembolism Risk in Microsurgical Breast Reconstruction

Cecil S. Qiu
1   Division of Plastic and Reconstructive Surgery, Northwestern University Feinberg School of Medicine, Chicago, Illinois
,
Sumanas W. Jordan
1   Division of Plastic and Reconstructive Surgery, Northwestern University Feinberg School of Medicine, Chicago, Illinois
,
Robert G. Dorfman
1   Division of Plastic and Reconstructive Surgery, Northwestern University Feinberg School of Medicine, Chicago, Illinois
,
Michael M. Vu
1   Division of Plastic and Reconstructive Surgery, Northwestern University Feinberg School of Medicine, Chicago, Illinois
,
Mohammed S. Alghoul
1   Division of Plastic and Reconstructive Surgery, Northwestern University Feinberg School of Medicine, Chicago, Illinois
,
John Y.S. Kim
1   Division of Plastic and Reconstructive Surgery, Northwestern University Feinberg School of Medicine, Chicago, Illinois
› Author Affiliations
Further Information

Publication History

21 May 2017

20 July 2017

Publication Date:
09 October 2017 (online)

    Permissions and Reprints

Abstract

Background Increased surgical duration can impact patient outcomes and operative efficiency metrics. In particular, there are studies suggesting that increased surgical duration can increase the risk of venous thromboembolism (VTE). One of the longer duration plastic surgery procedures commonly performed is microsurgical breast reconstruction. With the widening indications for multiple and “stacked” free flaps to reconstruct breasts, we endeavored to assess (1) the relationship between duration of microsurgical breast reconstruction and VTE; and (2) determine if a threshold operative time exists that connotes VTE higher risk.

Methods Patients from the American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP) between 2005 and 2014 who underwent microsurgical breast reconstruction were identified by Current Procedural Terminology code. Three models of multivariate logistic regression were used to characterize the adjusted risk for VTE by operative duration, bilaterality, the length of stay, and patient demographics.

Results A total of 4,782 patients who underwent microsurgical breast reconstruction were identified. Overall VTE incidence was 1.13%. The mean operative duration was 8:31 hours:minutes (standard deviation: 2:59). Operative duration was statistically associated with VTE in continuous, quintile, and dichotomized risk models. Beyond an operative duration of 11 hours, adjusted VTE risk increases fourfold corresponding to a number needed to harm of 45.8.

Conclusions Increasing surgical duration heightens the risk of VTE in microsurgical breast reconstruction. Increasing body mass index and age enhances this VTE risk. Moreover, limiting surgical duration to 11 hours or less can decrease VTE risk by fourfold vis-à-vis baseline.

Level of Evidence Risk, II.

Keywords

surgical duration - venous thromboembolism - breast reconstruction

Supplementary Material

 

  • References

  • 1 Albornoz CR, Cordeiro PG, Mehrara BJ. , et al. Economic implications of recent trends in U.S. immediate autologous breast reconstruction. Plast Reconstr Surg 2014; 133 (03) 463-470
    CrossrefPubMedGoogle Scholar
  • 2 Cemal Y, Albornoz CR, Disa JJ. , et al. A paradigm shift in U.S. breast reconstruction: Part 2. The influence of changing mastectomy patterns on reconstructive rate and method. Plast Reconstr Surg 2013; 131 (03) 320e-326e
    CrossrefPubMedGoogle Scholar
  • 3 Sbitany H, Wang F, Peled AW. , et al. Immediate implant-based breast reconstruction following total skin-sparing mastectomy: defining the risk of preoperative and postoperative radiation therapy for surgical outcomes. Plast Reconstr Surg 2014; 134 (03) 396-404
    CrossrefPubMedGoogle Scholar
  • 4 Wang F, Koltz PF, Sbitany H. Lessons learned from the American College of Surgeons National Surgical Quality Improvement Program Database: has centralized data collection improved immediate breast reconstruction outcomes and safety?. Plast Reconstr Surg 2014; 134 (05) 859-868
    CrossrefPubMedGoogle Scholar
  • 5 Grover R, Padula WV, Van Vliet M, Ridgway EB. Comparing five alternative methods of breast reconstruction surgery: a cost-effectiveness analysis. Plast Reconstr Surg 2013; 132 (05) 709e-723e
    CrossrefPubMedGoogle Scholar
  • 6 Matros E, Albornoz CR, Razdan SN. , et al. Cost-effectiveness analysis of implants versus autologous perforator flaps using the BREAST-Q. Plast Reconstr Surg 2015; 135 (04) 937-946
    CrossrefPubMedGoogle Scholar
  • 7 Razdan SN, Cordeiro PG, Albornoz CR. , et al. Cost- effectiveness analysis of breast reconstruction options in the setting of postmastectomy radiotherapy using the BREAST-Q. Plast Reconstr Surg 2016; 137 (03) 510e-517e
    CrossrefPubMedGoogle Scholar
  • 8 Office of the Surgeon General (US); National Heart, Lung, and Blood Institute (US). The Surgeon General's Call to Action to Prevent Deep Vein Thrombosis and Pulmonary Embolism. Rockville, MD: Office of the Surgeon General (US); 2008
    Google Scholar
  • 9 Pannucci CJ, Bailey SH, Dreszer G. , et al. Validation of the Caprini risk assessment model in plastic and reconstructive surgery patients. J Am Coll Surg 2011; 212 (01) 105-112
    CrossrefPubMedGoogle Scholar
  • 10 Pannucci CJ, MacDonald JK, Ariyan S. , et al. Benefits and risks of prophylaxis for deep venous thrombosis and pulmonary embolus in plastic surgery: a systematic review and meta-analysis of controlled trials and consensus conference. Plast Reconstr Surg 2016; 137 (02) 709-730
    CrossrefPubMedGoogle Scholar
  • 11 Ricci JA, Crawford K, Ho OA, Lee BT, Patel KM, Iorio ML. Practical guidelines for venous thromboembolism prophylaxis in free tissue transfer. Plast Reconstr Surg 2016; 138 (05) 1120-1131
    CrossrefPubMedGoogle Scholar
  • 12 Pannucci CJ. Evidence- based recipes for venous thromboembolism prophylaxis: a practical safety guide. Plast Reconstr Surg 2017; 139 (02) 520e-532e
    CrossrefPubMedGoogle Scholar
  • 13 Caprini JA, Arcelus JI, Reyna JJ. Effective risk stratification of surgical and nonsurgical patients for venous thromboembolic disease. Semin Hematol 2001; 38 (02) (Suppl. 05) 12-19
    PubMedGoogle Scholar
  • 14 Caprini JA. Thrombosis risk assessment as a guide to quality patient care. Dis Mon 2005; 51 (2-3): 70-78
    CrossrefPubMedGoogle Scholar
  • 15 Kim JY, Khavanin N, Rambachan A. , et al. Surgical duration and risk of venous thromboembolism. JAMA Surg 2015; 150 (02) 110-117
    CrossrefPubMedGoogle Scholar
  • 16 American College of Surgeons National Surgical Quality Improvement Program. User guide for the 2014 ACS NSQIP participant use data file (PUF) 2015. Available at: https://www.facs.org/~/media/files/quality%20programs/nsqip/nsqip_puf_userguide_2014.ashx . Accessed July 11, 2016.
    PubMedGoogle Scholar
  • 17 Shiloach M, Frencher Jr SK, Steeger JE. , et al. Toward robust information: data quality and inter-rater reliability in the American College of Surgeons National Surgical Quality Improvement Program. J Am Coll Surg 2010; 210 (01) 6-16
    CrossrefPubMedGoogle Scholar
  • 18 Fischer JP, Wes AM, Tuggle CT. , et al. Mastectomy with or without immediate implant reconstruction has similar 30-day perioperative outcomes. J Plast Reconstr Aesthet Surg 2014; 67 (11) 1515-1522
    CrossrefPubMedGoogle Scholar
  • 19 Kim JY, Khavanin N, Jordan SW. , et al. Individualized risk of surgical-site infection: an application of the breast reconstruction risk assessment score. Plast Reconstr Surg 2014; 134 (03) 351e-362e
    CrossrefPubMedGoogle Scholar
  • 20 Williams BA, Mandrekar JN, Mandrekar SJ, Cha SS, Furth AF. Finding optimal cutpoints for continuous covariates with binary and time-to-event outcomes. Mayo Clinic Department of Health Sciences Research, Technical Report Series #79; June 2006. Available at: http://www.mayo.edu/research/documents/biostat-79pdf/doc-10027230 . Accessed October 17, 2016
    PubMedGoogle Scholar
  • 21 Comfere T, Sprung J, Kumar MM. , et al. Angiotensin system inhibitors in a general surgical population. Anesth Analg 2005; 100 (03) 636-644
    CrossrefPubMedGoogle Scholar
  • 22 Hilsenbeck SG, Clark GM. Practical p-value adjustment for optimally selected cutpoints. Stat Med 1996; 15 (01) 103-112
    CrossrefPubMedGoogle Scholar
  • 23 McDonald JH. Chi-square test of independence. Handbook of Biological Statistics. 3rd ed. Baltimore, MD: Sparky House Publishing; 2014: 59-67
    Google Scholar
  • 24 Thabane L, Mbuagbaw L, Zhang S. , et al. A tutorial on sensitivity analyses in clinical trials: the what, why, when and how. BMC Med Res Methodol 2013; 13: 92
    CrossrefPubMedGoogle Scholar
  • 25 Lee PH. Is a cutoff of 10% appropriate for the change-in-estimate criterion of confounder identification?. J Epidemiol 2014; 24 (02) 161-167
    CrossrefPubMedGoogle Scholar
  • 26 Kahn SR, Shbaklo H, Lamping DL. , et al. Determinants of health-related quality of life during the 2 years following deep vein thrombosis. J Thromb Haemost 2008; 6 (07) 1105-1112
    CrossrefPubMedGoogle Scholar
  • 27 Elting LS, Escalante CP, Cooksley C. , et al. Outcomes and cost of deep venous thrombosis among patients with cancer. Arch Intern Med 2004; 164 (15) 1653-1661
    CrossrefPubMedGoogle Scholar
  • 28 Shahi A, Chen AF, Tan TL, Maltenfort MG, Kucukdurmaz F, Parvizi J. The Incidence and economic burden of in-hospital venous thromboembolism in the United States. J Arthroplasty 2017; 32 (04) 1063-1066
    CrossrefPubMedGoogle Scholar
  • 29 Lemaine V, McCarthy C, Kaplan K. , et al. Venous thromboembolism following microsurgical breast reconstruction: an objective analysis in 225 consecutive patients using low-molecular-weight heparin prophylaxis. Plast Reconstr Surg 2011; 127 (04) 1399-1406
    CrossrefPubMedGoogle Scholar
  • 30 Ashjian P, Chen CM, Pusic A, Disa JJ, Cordeiro PG, Mehrara BJ. The effect of postoperative anticoagulation on microvascular thrombosis. Ann Plast Surg 2007; 59 (01) 36-39 , discussion 39–40
    CrossrefPubMedGoogle Scholar
  • 31 Pannucci CJ, Dreszer G, Wachtman CF. , et al. Postoperative enoxaparin prevents symptomatic venous thromboembolism in high-risk plastic surgery patients. Plast Reconstr Surg 2011; 128 (05) 1093-1103
    CrossrefPubMedGoogle Scholar
  • 32 Rao S, Stolle EC, Sher S, Lin CW, Momen B, Nahabedian MY. A multiple logistic regression analysis of complications following microsurgical breast reconstruction. Gland Surg 2014; 3 (04) 226-231
    PubMedGoogle Scholar
  • 33 Masoomi H, Paydar KZ, Wirth GA, Aly A, Kobayashi MR, Evans GR. Predictive risk factors of venous thromboembolism in autologous breast reconstruction surgery. Ann Plast Surg 2014; 72 (01) 30-33
    CrossrefPubMedGoogle Scholar
  • 34 Tran BH, Nguyen TJ, Hwang BH. , et al. Risk factors associated with venous thromboembolism in 49,028 mastectomy patients. Breast 2013; 22 (04) 444-448
    CrossrefPubMedGoogle Scholar
  • 35 Nwaogu I, Yan Y, Margenthaler JA, Myckatyn TM. Venous thromboembolism after breast reconstruction in patients undergoing breast surgery: An American College of Surgeons NSQIP analysis. J Am Coll Surg 2015; 220 (05) 886-893
    CrossrefPubMedGoogle Scholar
  • 36 Fischer JP, Wes AM, Tuggle CT, Wu LC. Venous thromboembolism risk in mastectomy and immediate breast reconstruction: analysis of the 2005 to 2011 American College of Surgeons National Surgical Quality Improvement Program data sets. Plast Reconstr Surg 2014; 133 (03) 263e-273e
    CrossrefPubMedGoogle Scholar
  • 37 Canizares O, Mayo J, Soto E, Allen RJ, Sadeghi A. Optimizing efficiency in deep inferior epigastric perforator flap breast reconstruction. Ann Plast Surg 2015; 75 (02) 186-192
    CrossrefPubMedGoogle Scholar
  • 38 Kaplan JL, Allen RJ. Cost-based comparison between perforator flaps and TRAM flaps for breast reconstruction. Plast Reconstr Surg 2000; 105 (03) 943-948
    CrossrefPubMedGoogle Scholar
  • 39 Pannucci CJ, Chang EY, Wilkins EG. Venous thromboembolic disease in autogenous breast reconstruction. Ann Plast Surg 2009; 63 (01) 34-38
    CrossrefPubMedGoogle Scholar
  • 40 Cooney CM, Sebai ME, Ogbuagu O, Devulapalli C, Manahan MA, Rosson GD. Matching procedures at the time of immediate breast reconstruction: An American College of Surgeons National Surgical Quality Improvement Program Study of 24,191 patients. Plast Reconstr Surg 2016; 138 (06) 959e-968e
    CrossrefPubMedGoogle Scholar
  • 41 Ay C, Pabinger I, Cohen AT. Cancer-associated venous thromboembolism: Burden, mechanisms, and management. Thromb Haemost 2017; 117 (02) 219-230
    Article in Thieme ConnectPubMedGoogle Scholar
  • 42 Pannucci CJ, Kovach SJ, Cuker A. Microsurgery and the hypercoagulable state: a hematologist's perspective. Plast Reconstr Surg 2015; 136 (04) 545e-552e
    CrossrefPubMedGoogle Scholar
  • 43 Craig ES, Walker ME, Fusi S. Venous thromboembolism risk factors in breast cancer patients undergoing deep inferior epigastric perforator flap reconstruction. Microsurgery 2012; 32 (04) 334-335
    CrossrefPubMedGoogle Scholar
  • 44 Wade RG, Marongiu F, Sassoon EM, Haywood RM, Ali RS, Figus A. Contralateral breast symmetrisation in unilateral DIEP flap breast reconstruction. J Plast Reconstr Aesthet Surg 2016; 69 (10) 1363-1373
    CrossrefPubMedGoogle Scholar
  • 45 Gosseringer N, Mani M, Cali-Cassi L, Papadopoulou A, Rodriguez-Lorenzo A. Benefits of two or more senior microsurgeons operating simultaneously in microsurgical breast reconstruction: Experience in a Swedish medical center. Microsurgery 2017; 37 (05) 416-420
    CrossrefPubMedGoogle Scholar
  • 46 Smit JM, Dimopoulou A, Liss AG. , et al. Preoperative CT angiography reduces surgery time in perforator flap reconstruction. J Plast Reconstr Aesthet Surg 2009; 62 (09) 1112-1117
    CrossrefPubMedGoogle Scholar
  • 47 Tong WM, Dixon R, Ekis H, Halvorson EG. The impact of preoperative CT angiography on breast reconstruction with abdominal perforator flaps. Ann Plast Surg 2012; 68 (05) 525-530
    CrossrefPubMedGoogle Scholar
  • 48 Ohkuma R, Mohan R, Baltodano PA. , et al. Abdominally based free flap planning in breast reconstruction with computed tomographic angiography: systematic review and meta-analysis. Plast Reconstr Surg 2014; 133 (03) 483-494
    CrossrefPubMedGoogle Scholar
  • 49 Casey III WJ, Chew RT, Rebecca AM, Smith AA, Collins JM, Pockaj BA. Advantages of preoperative computed tomography in deep inferior epigastric artery perforator flap breast reconstruction. Plast Reconstr Surg 2009; 123 (04) 1148-1155
    CrossrefPubMedGoogle Scholar
  • 50 Weichman KE, Lam G, Wilson SC. , et al. The impact of two operating surgeons on microsurgical breast reconstruction. Plast Reconstr Surg 2017; 139 (02) 277-284
    CrossrefPubMedGoogle Scholar
  • 51 Bauermeister AJ, Zuriarrain A, Newman M, Earle SA, Medina III MA. Impact of continuous two-team approach in autologous breast reconstruction. J Reconstr Microsurg 2017; 33 (04) 298-304
    Article in Thieme ConnectPubMedGoogle Scholar
  • 52 Hultman CS, Kim S, Lee CN. , et al. Implementation and analysis of a lean six sigma program in microsurgery to improve operative throughput in perforator flap breast reconstruction. Ann Plast Surg 2016; 76 (Suppl. 04) S352-S356
    CrossrefPubMedGoogle Scholar
  • 53 Sweetland S, Green J, Liu B. , et al; Million Women Study collaborators. Duration and magnitude of the postoperative risk of venous thromboembolism in middle aged women: prospective cohort study. BMJ 2009; 339: b4583
    CrossrefPubMedGoogle Scholar
  • 54 Kim EK, Eom JS, Ahn SH, Son BH, Lee TJ. The efficacy of prophylactic low-molecular-weight heparin to prevent pulmonary thromboembolism in immediate breast reconstruction using the TRAM flap. Plast Reconstr Surg 2009; 123 (01) 9-12
    PubMedGoogle Scholar
  • 55 Keith JN, Chong TW, Davar D, Moore AG, Morris A, Gimbel ML. The timing of preoperative prophylactic low-molecular-weight heparin administration in breast reconstruction. Plast Reconstr Surg 2013; 132 (02) 279-284
    CrossrefPubMedGoogle Scholar
  • 56 Liao EC, Taghinia AH, Nguyen LP, Yueh JH, May Jr JW, Orgill DP. Incidence of hematoma complication with heparin venous thrombosis prophylaxis after TRAM flap breast reconstruction. Plast Reconstr Surg 2008; 121 (04) 1101-1107
    CrossrefPubMedGoogle Scholar
  • 57 Koch CG, Li L, Hixson E, Tang A, Phillips S, Henderson JM. What are the real rates of postoperative complications: elucidating inconsistencies between administrative and clinical data sources. J Am Coll Surg 2012; 214 (05) 798-805
    CrossrefPubMedGoogle Scholar